azathioprine has been researched along with mesalamine in 297 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (1.01) | 18.7374 |
1990's | 31 (10.44) | 18.2507 |
2000's | 102 (34.34) | 29.6817 |
2010's | 142 (47.81) | 24.3611 |
2020's | 19 (6.40) | 2.80 |
Authors | Studies |
---|---|
Lipsky, JJ; Mahoney, DW; Mays, DC; Sandborn, WJ; Tremaine, WJ; Van Os, EC; Zins, BJ; Zinsmeister, AR | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Knuckley, B; Luo, Y; Thompson, PR | 1 |
Collins, MT; Shin, SJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fischbach, W | 1 |
Goldstein, F | 1 |
Anania, T; Clearfield, HR; Murthy, SN | 1 |
Goebell, H; Kölbel, C | 1 |
Bender, SW; Kirchmann, H; Posselt, HG | 1 |
Gerok, W; Schölmerich, J | 1 |
Lennard-Jones, JE | 1 |
Andus, T; Gross, V; Schölmerich, J | 1 |
Szumlanski, CL; Weinshilboum, RM | 1 |
Stark, ME; Tremaine, WJ | 1 |
Gendre, JP | 1 |
van Hogezand, RA | 1 |
Derkx, B; Radema, S; Stronkhorst, A; Taminiau, J; Tytgat, G; van Deventer, S; Wortel, C | 1 |
Baratz, M; Gilat, T; Hallak, A; Halpern, Z; Rabau, M; Santo, M; Werbin, N | 1 |
Lancho, A; López-Róses, L; Pérez de Llano, LA; Soilán del Cerro, JL | 1 |
Peppercom, MA | 1 |
Driessen, WM; Keuning, JJ; van Beek, M; Veldman, W | 1 |
Keljo, DJ; Sugerman, KS | 1 |
Cirigliano, MD; Lichtenstein, GR; Stotland, BR | 1 |
Tytgat, GN; van Deventer, SJ | 1 |
Breslin, NP; Sutherland, LR | 1 |
Aigrain, Y; Besnard, M; Cézard, JP; Debrun, A; Delagausie, P; Faure, C; Ferkdadji, L; Jaby, O; Mougenot, JF; Navarro, J; Peuchmaur, M | 1 |
Lowry, PW; Sandborn, WJ | 1 |
Lowry, PW; Sandborn, WJ; Szumlanski, CL; Weinshilboum, RM | 1 |
Adler, G; Glasbrenner, B; Güthner, C; Hetzel, W; Mattfeld, T; Röcken, C | 1 |
Cosnes, J; Elefant, E; Gendre, JP; Marteau, P; Modigliani, R; Rambaud, JC; Tennenbaum, R | 1 |
Hüppe, D; Schenck, B; Tromm, A | 1 |
Autret-Leca, E; Casanova, JL; Cissoko, H; Jonville-Béra, AP; Lenain, H; Rivière, MF; Saugier, J | 1 |
Baert, F; Rutgeerts, P | 1 |
Gleim, GW; Kim, PS; Korelitz, BI; Zlatanic, J | 1 |
Kougo, Y | 1 |
Colombel, JF; Desreumaux, P; Ectors, N; Geboes, K; Jouret, A; Rutgeerts, P | 1 |
Green, JR | 1 |
Cherikuri, A; Donnelly, S; Farrell, RJ; Keeling, PW; Kelleher, D; Long, A; Mahmud, N; Murphy, A; O'Toole, D; Weir, DG | 1 |
Hiwatashi, N | 1 |
Present, DH | 1 |
Glintborg, B | 1 |
Faubion, WA; Sandborn, WJ | 1 |
Dassopoulos, T; Hanauer, SB | 1 |
Aguilera, V; Berenguer, J; Hinojosa, J; Molés, JR; Nos, P; Pastor, M; Ponce, J | 1 |
Evans, DF; Kumar, D; Nugent, SG; Rampton, DS | 1 |
Rutgeerts, PJ | 1 |
Binder, V; Munkholm, P | 1 |
Bellanger, J; Cacoub, P; Godeau, P; Hoang, C; Piette, JC; Sbaï, A; Toan, SV | 1 |
Franklin, CL; Lipsky, JJ; Loftus, EV; Lowry, PW; Mays, DC; Sandborn, WJ; Szumlanski, CL; Tremaine, WJ; Weaver, AL; Weinshilboum, RM | 1 |
Campbell, S; Ghosh, S | 1 |
Desager, JP; Dewit, O; Horsmans, Y; Vanheuverzwyn, R | 1 |
Kamm, MA | 2 |
Cézard, JP; Faure, C; Hugot, JP; Le Large-Guiheneuf, C; Mougenot, JF; Munck, A; Navarro, J | 1 |
Farthing, MJ | 1 |
Niemelä, S | 1 |
Färkkilä, M; Järvinen, HJ; Jussila, A | 1 |
Brandt, J; Dijkmans, B; Dougados, M; Khan, M; Maksymowych, W; van der Linden, S | 1 |
Castro Fernández, M; Galán Jurado, V; García Díaz, E; Rodríguez Alonso, C; Romero, M | 1 |
Schölmerich, J | 1 |
Fleig, WE | 1 |
Nagy, F | 1 |
France, R; Kinney, T; Kozarek, R; Patterson, D; Rawlins, M | 1 |
Kullak-Ublick, GA; Rammert, Ch | 1 |
Beglinger, Ch | 1 |
Archimandritis, A; Batziou, E; Galanopoulos, G; Sipsas, N; Toubanakis, C; Tzivras, M | 1 |
Bauret, P; Berthier, E; Blanc, F; Blayac, JP; Fabbro-Peray, P; Hanslik, B; Hillaire-Buys, D; Larrey, D; Melki, M; Pageaux, GP; Perney, P; Roques, V | 1 |
Chu, XQ; Jia, LM; Shi, XH; Wang, FM; Zheng, JJ | 1 |
Curto, EV; Davis, RL; Dooley, TP; Elson, CO; Lambert, GW; Reddy, SP; Wilborn, TW | 1 |
Fölsch, UR; Kühbacher, T; Schreiber, S | 1 |
Ardizzone, S; Bianchi Porro, G; Colombo, E; Danelli, PG; Imbesi, V; Maconi, G; Molteni, M; Radice, E; Russo, A; Sampietro, GM; Taschieri, AM | 1 |
Bischoff, SC; Fleig, W; Reissmann, A | 1 |
Bernal, I; Boix, J; Cabré, E; Casalots, A; Domènech, E; Esteve-Comas, M; García-Planella, E; Gassull, MA; Piñol, M; Scala, L | 1 |
Binder, V; Jess, T; Langholz, E; Munkholm, P; Winther, KV | 1 |
Beaugerie, L; Bouhnik, Y; Cosnes, J; Etienney, I; Gendre, JP; Lémann, M; Matuchansky, C; Modigliani, R; Rambaud, JC | 1 |
Vetter, C | 1 |
Tomomasa, T | 1 |
Ardizzone, S; Bianchi Porro, G; Colombo, E; Imbesi, V; Maconi, G; Russo, A | 1 |
Kashima, K; Miyajima, H; Murakami, K; Nasu, M; Oda, M; Ono, M; Sato, R; Watanabe, K | 1 |
Dixon, A; Hart, A; Robinson, R; Wurm, P | 1 |
Cohen, RD | 1 |
Graziadei, IW; Kronberger, IE; Vogel, W | 1 |
Sandborn, WJ | 2 |
Amigo Echenagusía, A; González Carro, P; Lafuente, R; Legaz Huidobro, ML; Pérez Roldán, F; Roncero García Escribano, O | 1 |
Allgayer, H; Kruis, W | 1 |
Banks, P; Bousvaros, A; Burakoff, R; Friedman, S; Hande, S; Makrauer, F; Maurer, R; Reddy, S; Wilson-Rich, N; Zholudev, A | 1 |
De Pedro-Esteban, A; González-Carro, P; Legaz-Huidobro, ML; Pérez-Roldán, F; Roncero García-Escribano, O; Ruiz-Carrillo, F; Soto-Fernández, S; Valbuena-González, M | 1 |
Pierik, M; Rutgeerts, P; Vermeire, S; Vlietinck, R | 1 |
Phuapradit, P; Pienvichit, P; Pornkul, R; Sornmayura, P; Treepongkaruna, S; Wisedopas, N | 1 |
Büning, C; Lochs, H | 1 |
Dassopoulos, T; Ginsburg, PM | 1 |
Mudter, J; Neurath, MF | 1 |
Dilger, K; Herfarth, H; Lukas, M; Müller, R; Obermeier, F; Schölmerich, J; Tjaden, C | 1 |
Cottone, M; Modesto, I; Orlando, A; Scimeca, D | 1 |
Bernal, I; Cabré, E; Domènech, E; Garcia-Planella, E; Gassull, MA; Mañosa, M; Marín, L; Navarro, M | 1 |
Kolho, KL; Ruuska, T; Savilahti, E | 1 |
Boubaker, J; Filali, A; Kallel, L; Karoui, S | 1 |
Bengmark, S; Dörffel, Y; Lochs, H; Loening-Baucke, V; Swidsinski, A | 1 |
Abadom, V; Cuffari, C; Oliva-Hemker, MM; Thompson, RE | 1 |
Dilger, K; Herfarth, H; Lukas, M; Müller, R; Schaeffeler, E; Schwab, M; Strauch, U | 1 |
Timmer, A | 1 |
Lakatos, L; Lakatos, PL | 3 |
Burakoff, R; Levine, JS | 1 |
Akobeng, AK | 1 |
Detsky, A; Kennedy, ED; Llewellyn-Thomas, HA; McLeod, RS; Steinhart, AH; To, T | 1 |
Afzal, NA; Beattie, RM; Griffiths, DM; Howarth, LJ; Wiskin, AE | 1 |
Edwards, CM; Probert, CS; Shah, JA | 1 |
Hanauer, SB | 1 |
Baldassano, RN; Davis, CM; Hommel, KA | 1 |
Kornbluth, A; Swaminath, A | 1 |
Bartoli, F; Decorti, G; Malusa', N; Marino, S; Martelossi, S; Stocco, G; Ventura, A | 1 |
Algaba, A; Bermejo, F; Calvo, M; Carneros, JA; Gisbert, JP; López, P; Lopez-Sanroman, A; Luna, M; Martín-Arranz, MD; Menchén, L; Mendoza, JL; Opio, V; Pérez-Calle, JL; Taxonera, C; Van-Domselaar, M; Vera, I | 1 |
Miller, V; Whorwell, PJ | 1 |
Basso, MS; Bracci, F; Castro, M; Diamanti, A; Gambarara, M; Noto, C; Papadatou, B | 1 |
Burakoff, R | 1 |
Mayberry, H; Mayberry, JF; Moshkovska, T | 1 |
Danko, K; Dezso, B; Gunasekera, W; Kulcsar, I; Lukacs, S; Nagy-Toldi, A; Szabo, N | 1 |
Dillon, J; Green, J; Moran, G | 1 |
Cho, SW; Chung, JY; Hwang, JC; Lee, KJ; Park, BJ; Sin, SJ | 1 |
Jang, BI; Kim, KO | 1 |
Choi, YJ; Chung, WC; Kim, HW; Lee, JM; Lee, JR; Lee, KM; Paik, CN; Yang, JM | 1 |
Choi, HS; Hahm, JS; Han, DS; Joo, YW; Lee, HL; Lee, OY; Son, CN; Yoon, BC | 1 |
Rogler, G; Vavricka, SR | 1 |
Cao, Q; Gao, M; Shang, Y; Si, J; Zhu, Q | 1 |
Matsumoto, K; Umegae, S; Yamamoto, T | 1 |
Belluzzi, A; Caponi, A; Roda, E; Roda, G | 1 |
Feller, ER; Harris, A; Shah, SA | 1 |
Esposti, SD; Saha, S | 1 |
Paviotti, A; Sorrentino, D | 1 |
McKenzie, M; McLeod, RS; Parkes, R; Ross, S; Wolff, BG | 1 |
Siegmund, SV; Singer, MV; Zimmerer, T | 1 |
Canaparo, R; Castagno, F; Crocellà, L; D'Antico, S; Daperno, M; Ercole, E; Lavagna, A; Pera, A; Rigazio, C; Rocca, R; Serpe, L; Sostegni, R; Vernetto, A; Zara, G | 1 |
Baraboutis, IG; Georgiadis, D; Georgiou, O; Karamanolis, DG; Papastamopoulos, V; Rodias, M; Skoutelis, A; Viazis, N; Vlachogiannakos, J | 1 |
Baldassano, RN; Denson, LA; Hommel, KA; Ingerski, LM | 1 |
Croft, NM; Dawson, R; Goodhand, J; Hefferon, M; Lindsay, JO; Swanson, G; Tshuma, N; Wahed, M | 1 |
Cury, DB; Moss, AC | 1 |
Greenley, RN; Hommel, KA; Kunz, JH | 1 |
Baldassano, RN; Hommel, KA | 1 |
Cheon, JH; Chung, MJ; Kim, NK; Kim, SU; Kim, TI; Kim, WH; Park, JJ | 1 |
Arasaradnam, R; Da-Silva, N; Getliffe, K; Nwokolo, C; Oo, Y; Sung, E | 1 |
Das, K; Pitchumoni, CS; Rubin, A | 1 |
Al-Hassi, HO; Guenther, T; Hart, AL; Kamm, MA; Knight, SC; Ng, SC; Plamondon, S; Stagg, AJ | 1 |
Fernández-Rodríguez, C; López-Serrano, P; Pérez-Calle, JL | 1 |
Allorge, D; Broly, F; Colombel, JF; Cortot, A; Jouet, JP; Torres, J; Tremblay, L | 1 |
Andrejic, J; Berkelhammer, C; Dennis, M; Rojas-Balcazar, J | 1 |
Marinaki, AM; Sanderson, JD; Smith, MA | 1 |
Bischoff, A | 1 |
Boulieu, R; Lachaux, A; Le Gall, C; Nguyen, TM | 1 |
Calderón, R; Delgado, E; Enciso, C; Estrada, S; García-Campos, F; Ramírez de la Piscina, P; Salvador, M; Zabaleta, S | 1 |
Choe, YH; Kim, MJ; Lee, HJ; Lee, JH; Lee, JS | 1 |
Procházka, M; Procházka, V; Urbánek, K; Vinklerová, I | 1 |
Annese, V; Brandimarte, G; D'Amico, T; Danese, S; Di Giulio, E; Di Rosa, S; Elisei, W; Forti, G; Gasbarrini, A; Giglio, A; Giorgetti, GM; Hassan, C; Imeneo, M; Larussa, T; Luzza, F; Modeo, ME; Morini, S; Papa, A; Pistoia, MA; Rodino', S; Sacca', N; Sebkova, L; Tursi, A | 1 |
Angelberger, S; Bar-Meir, S; Dilger, K; Greinwald, R; Herrlinger, KR; Lukas, M; Mueller, R; Petritsch, W; Reinisch, W; Schaeffeler, E; Schwab, M; Shonova, O; Stange, EF; Teml, A | 1 |
de Boer, NK; de Graaf, P; Hooymans, PM; Jharap, B; Karner, S; Mulder, CJ; Schwab, M; van Bodegraven, AA; Veldkamp, AI; Wong, DR | 1 |
Iwakiri, R; Kitayama, A; Misago, N; Narisawa, Y; Okawa, T | 1 |
Ford, AC | 1 |
Harbaum, L; Langner, C; Siebert, F | 1 |
Brotons, A; García-Sepulcre, MF; Grau, MC; Gutiérrez, F; Masiá, M; Ramos, JM | 1 |
Andrews, JM; Bampton, P; Mountifield, RE; Muller, K; Prosser, R | 1 |
Bousvaros, A; Crandall, W; Evans, J; Griffiths, A; Grossman, A; Hyams, JS; Kappelman, MD; Kay, M; Keljo, D; Leleiko, N; Lerer, T; Mack, D; Markowitz, J; Michail, S; Oliva-Hemker, M; Otley, A; Pfefferkorn, M; Rosh, J; Saeed, S; Samson, C; Stephens, M; Sudel, B | 1 |
Reinisch, W; Stange, EF | 1 |
Ford, AC; Hamlin, PJ; Jackson, EL | 1 |
Denson, LA; Hente, E; Herzer, M; Hommel, KA; Ingerski, LM | 2 |
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
Oldenburg, B; Siersema, PD; Smeets, HM; van der Heijden, GJ; van Oijen, MG; van Schaik, FD | 1 |
Baricordi, O; Borgoni, R; Cifalà, V; Galuppi, C; Gullini, S; Melchiorri, L; Rizzo, R; Zelante, A | 1 |
Bosque López, MJ; Rocamora Durán, V; Royo Escosa, V; Sansó Sureda, A; Sapiña Camaró, A | 1 |
Bass, D; Garber, A; Honkanen, A; Park, KT; Perez, F; Tsai, R | 1 |
Jakobsen, C; Munkholm, P; Paerregaard, A; Wewer, V | 1 |
Lightdale, JR; Samnaliev, M | 1 |
Chang, HK; Kang, SJ; Kim, JB; Kim, KJ; Moon, W; Park, MI; Park, MJ; Park, SJ | 1 |
Cheifetz, AS; Doherty, GA; Miksad, RA; Moss, AC | 1 |
Meier, J; Sturm, A | 1 |
Chaparro, M; Gisbert, JP; Gomollón, F | 1 |
Denson, LA; Guilfoyle, SM; Hente, EA; Herzer, M; Hommel, KA; Ingerski, LM; Odell, S | 1 |
Bigard, MA; Billioud, V; Bresler, L; Chevaux, JB; Gueant, JL; Oussalah, A; Peyrin-Biroulet, L; Pillot, C; Williet, N | 1 |
Balogh, M; David, G; Erdelyi, Z; Golovics, PA; Horvath, A; Kiss, LS; Komaromi, E; Lakatos, L; Lakatos, PL; Lovasz, BD; Mester, G; Molnar, C; Pandur, T; Szathmari, M; Szipocs, I; Veres, G | 1 |
Bommelaer, G; Buisson, A; Chevaux, JB; Peyrin-Biroulet, L | 1 |
Stiefelhagen, P | 3 |
Choi, CH; Jung, SA; Kim, WH; Kim, YH; Kim, YS; Lee, BI; Lee, H; Lee, KM; Ye, BD | 1 |
Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD | 1 |
Dijkstra, G; Nieuwenhuijs, VB; Ploeg, RJ; van Loo, ES | 1 |
Assulin, Y; Beer-Gabel, M; Chowers, Y; Lahat, A | 1 |
Ben-Horin, S; de Haar, C; Ehehalt, R; Higgins, P; Karrasch, T; Latella, G; Rieder, F; Rogler, G; Sans, M; Scaldaferri, F; Schirbel, A; Velin, D; Wehkamp, J | 1 |
Armuzzi, A; D'Haens, G; Griffiths, A; Lukas, M; Pineton de Chambrun, G; Preiss, JC; Reinisch, W; Sladek, M; Van Assche, G | 1 |
Archavlis, E; Lariou, C; Mantzaris, GJ; Papamichael, K | 1 |
Balogh, M; Dávid, G; Erdélyi, Z; Golovics, PA; Horváth, A; Kiss, LS; Komáromi, E; Lakatos, L; Lakatos, PL; Lovász, BD; Mester, G; Molnár, C; Pandur, T; Szathmári, M; Szipocs, I | 1 |
Actis, GC; Pellicano, R; Rizzetto, M; Rosina, F | 1 |
Bi, HC; Chen, BL; Chen, MH; Ding, L; Gao, X; Hu, PJ; Huang, M; Liu, H; Wang, XD; Xiao, YL; Zhang, FB; Zhao, LZ | 1 |
Bollegala, N; Brill, H; Marshall, JK | 1 |
Ascolani, M; Biancone, L; Boirivant, M; Cossu, A; Pallone, F | 1 |
Atreya, R; Neumann, H; Neurath, MF | 1 |
Macdonald, JK; McDonald, JW; Timmer, A; Tsoulis, DJ | 1 |
Hibi, T; Yajima, T | 1 |
Fangbin, Z; Feng, X; Liang, D; Min, H; Minhu, C; Pinjin, H; Xiang, G | 1 |
Aldeguer, X; Busquets, D | 1 |
Cho, JY; Heo, SW; Ju, DU; Kim, EJ; Kim, EY; Oh, HK; Park, KC; Ryu, JI | 1 |
Albuquerque, A; Cabral, J; Dias, CC; Lopes, S; Macedo, G; Macedo, GN; Magro, F; Nazareth, N; Santos-Antunes, J; Sarmento, A; Sobrinho-Simões, J; Teixeira, S; Vilas-Boas, F | 1 |
Watanabe, T; Yamamoto, T | 1 |
Chebli, JM; Chebli, LA; da Rocha Ribeiro, TC; de Azevedo Lucca, F; de Lima Pace, FH; de Miranda Chaves, LD; de Oliveira Zanini, KA; de Souza, GS; Furtado, MC; Gaburri, PD; Ribeiro, LC; Vidigal, FM; Zanini, A | 1 |
Assandri, L; Bodini, G; Bruzzone, L; Dulbecco, P; Fazio, V; Frigo, AC; Marabotto, E; Mazza, F; Savarino, E; Savarino, V | 1 |
Chaparro, M; Díaz, R; Gisbert, JP; Rodríguez-Grau, Mdel C | 1 |
Andersson, M; Basit, S; Jess, T; Langholz, E; Nielsen, NM; Rungoe, C; Wohlfahrt, J | 1 |
Ban, L; Card, T; Fiaschi, L; Tata, LJ | 1 |
Brito, M; Correia, LA; Cravo, ML; de Deus, JR; Ferreira, PA; Maio, RF; Ministro, P; Moura-Santos, P; Peixe, P; Sousa, P; Tavares, L; Velho, S; Velosa, JF | 1 |
Ruemmele, FM; Turner, D | 1 |
Bach, H; Bressler, B; Grist, J; Silverberg, MS; Stempak, JM; Xia, A | 1 |
Blonski, W; Buchner, AM; Lichtenstein, GR | 1 |
Andersson, P; Myrelid, P; Norblad, R; Söderholm, JD | 1 |
De Rosa, M; Delrio, P; Duraturo, F; Galatola, M; Izzo, P; Martinelli, M; Miele, E; Paparo, L; Rega, D; Rossi, GB; Staiano, A; Strisciuglio, C | 1 |
Danese, S; Fiorino, G; Gilardi, D; Naccarato, P; Sociale, OR | 1 |
Rogler, G; Scharl, M; Schoepfer, AM; Vavricka, SR | 1 |
Bernal, I; Boix, J; Cabré, E; Domènech, E; Lorenzo-Zúñiga, V; Mañosa, M; Marín, L; Moreno, V; Zabana, Y | 1 |
Bae, GH; Kim, EJ; Kim, EY; Lee, HC; Lee, TS; Oh, HK; Song, JE | 1 |
Byeon, JS; Jung, KW; Kim, J; Kim, JH; Kim, JW; Kim, KJ; Kim, SO; Myung, SJ; Park, SH; Park, SK; Yang, DH; Yang, SK; Ye, BD | 1 |
Indriolo, A; Ravelli, P | 1 |
Hofmann-Aßmus, M | 1 |
Handa, O; Ishikawa, T; Itoh, Y; Iwamoto, Y; Kamada, K; Katada, K; Kondo, N; Konishi, H; Naito, Y; Okayama, T; Sakagami, J; Takagi, T; Uchiyama, K; Yagi, N; Yasuda, H; Yoshida, N | 1 |
Hamlin, J; Ninan, S | 1 |
Chapman, CG; Rubin, DT | 1 |
Deepak, P; Stobaugh, DJ | 1 |
Evgenidis, N; Giouleme, O; Kouklakis, G; Mpoumponaris, A; Nakos, A; Patsiaoura, K; Pitiakoudis, M; Vassiliadis, T; Zezos, P | 1 |
Akobeng, AK; Gordon, M; Taylor, K; Thomas, AG | 1 |
Cierny, D; Hlavaty, T; Huorka, M; Killinger, Z; Koller, T; Krajcovicova, A; Letkovsky, J; Miznerova, E; Nevidanska, M; Payer, J; Toth, J; Zelinkova, Z | 1 |
Castro, AC; Chebli, JM; Chebli, LA; da Rocha Ribeiro, TC; de Lima Pace, FH; de Oliveira Zanini, KA; de Souza, GS; do Valle Pinheiro, B; Furtado, MC; Gaburri, PD; Machado de Oliveira, J; Pinto, AL; Ribeiro, LC; Vidigal, FM; Zanini, A | 1 |
Abraham, P; Ahuja, V; Bhasin, DK; Bhatia, SJ; Choudhuri, G; Dadhich, S; Desai, D; Ganesh Pai, C; Ghoshal, UC; Goswami, BD; Issar, SK; Jain, AK; Jayanthi, V; Kochhar, R; Loganathan, G; Makharia, GK; Misra, SP; Pal, S; Perakath, B; Philip, M; Pulimood, A; Puri, AS; Ramakrishna, BS; Ray, G; Singh, SP; Sood, A; Subramanian, V | 1 |
Cuzzoni, E; De Iudicibus, S; Decorti, G; Favretto, D; Lionetti, P; Malusà, N; Martelossi, S; Pozzi, E; Stocco, G; Ventura, A | 1 |
Broekman, MM; de Jong, DJ; Hoentjen, F; Kerstholt, M; Leijten, A; Peters, WH; Roelofs, HM; Wanten, GJ; Wong, DR | 1 |
Choe, YH; Choi, SY; Kang, B; Kim, JW; Kim, MJ; Lee, MN; Lee, SY; Woo, SY | 1 |
Asaoka, K; Gekka, M; Kato, Y; Nishihara, H; Nomura, M; Sugiyama, T | 1 |
Hawthrone, AB | 1 |
Ashizuka, S; Inatsu, H; Kita, T; Kitamura, K | 1 |
Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S | 1 |
Chande, N; Feagan, BG; Marshall, JK; Nelson, S; Parker, CE; Sandborn, WJ; Seow, CH | 1 |
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
Burnand, B; Froehlich, F; Maillard, MH; Michetti, P; Pittet, V; Vaucher, C | 1 |
Cheon, JH; Kim, JH; Kim, TI; Kim, WH; Lee, HJ; Park, SJ; Park, Y | 1 |
Eun, CS; Han, DS; Kim, JF; Kim, YS; Kwak, MJ; Lee, AR; Park, DI; Yang, SK | 1 |
Brynskov, J; Ciocalteu, A; Hendel, J; Karstensen, JG; Klausen, P; Klausen, TW; Riis, LB; Săftoiu, A; Vilmann, P | 1 |
Carpio, D; Fernandez-Salgado, E; Puga, M; Sampil, M; Zamora, MJ | 1 |
Choe, YH; Choi, SY; Kang, B; Kim, HS; Kim, K; Lee, YM | 1 |
Bálint, A; Bor, R; Csontos, Á; Farkas, K; Gábor, Z; Hegede, G; Horváth, G; Juhász, M; Lakner, L; Miheller, P; Milassin, Á; Molnár, T; Nagy, F; Palatka, K; Rácz, I; Rutka, M; Szabó, A; Szepes, Z; Szűcs, M; Vincze, Á; Zsigmond, F; Zsóri, Á | 1 |
Chande, N; MacDonald, JK; McDonald, JW; Patton, PH; Timmer, A | 1 |
Grossman, AB; Maxwell, EC | 1 |
Charpentier, C; Cheddani, H; Dauchet, L; Dupas, JL; Fumery, M; Gower-Rousseau, C; Marie Bouvier, A; Pariente, B; Peyrin-Biroulet, L; Savoye, G | 1 |
Bagga, R; Jain, P; Rawal, P; Seth, AK | 1 |
Ghazi, LJ; Latushko, A | 1 |
Chande, N; MacDonald, JK; Parker, CE; Townsend, CM | 1 |
Bodini, G; De Maria, C; Dulbecco, P; Furnari, M; Giannini, EG; Marabotto, E; Savarino, E; Savarino, V | 1 |
Christensen, E; Rowinski, SA | 1 |
Boice, J; Colombel, JF; Cornillie, F; D'Haens, G; Ghosh, S; Hommes, DW; Huang, Z; Huyck, S; Lindgren, S; Panes, J; Prantera, C; Reinisch, W | 1 |
Jia, J; Lu, Y; Shen, H; Shen, Z; Zhang, L; Zheng, K; Zhu, L | 1 |
Dorofeyev, AE; Dorofeyeva, AA; Rassokhina, OA | 1 |
Augusto Benevenuto de Andrade, B; Bufalino, A; Caxias Travassos, D; Fernandes, D; Tavares Dos Santos, H | 1 |
Kandolf-Sekulović, L; Mijušković, Ž; Milenković, Z; Pecelj-Broćić, T; Tarabar, D; Tarabar, O; Tatomirović, Ž | 1 |
Ray, G | 1 |
Andoh, A; Araki, H; Endo, K; Hanai, H; Hiraoka, S; Hisamatsu, T; Hokari, R; Ikeya, K; Ishiguro, Y; Kakuta, Y; Kawai, Y; Kinouchi, Y; Kobayashi, T; Masamune, A; Matsumoto, T; Miura, M; Mizuno, S; Moroi, R; Motoya, S; Naganuma, M; Nagasaki, M; Naito, T; Nakagawa, S; Nakagawa, T; Nakamura, S; Nakase, H; Nishida, A; Okamoto, D; Onodera, K; Sakuraba, H; Sasaki, M; Shiga, H; Shimosegawa, T; Shinozaki, M; Suzuki, Y; Takagawa, T; Takahara, M; Toyonaga, T; Yanai, S | 1 |
Effraimidis, G; Goumas, K; Kothonas, F; Loi, V; Myroforidis, A; Palioura, E; Paschou, SA; Poulou, A; Vryonidou, A | 1 |
Bergquist, A; Bottai, M; Höijer, J; Söderberg-Löfdal, K; Stokkeland, K | 1 |
Asboth, M; Baumgartner, M; Evstatiev, R; Frick, A; Gasche, C; Gmainer, C; Jimenez, K; Khare, V; Krnjic, A; Lang, M | 1 |
Afif, W; Bernstein, CN; Bitton, A; Borgaonkar, M; Bressler, B; Chauhan, U; Halloran, B; Jones, J; Kennedy, E; Khanna, R; Leontiadis, GI; Loftus, EV; Marshall, JK; Meddings, J; Moayyedi, P; Murthy, S; Panaccione, R; Plamondon, S; Rosenfeld, G; Schwartz, D; Seow, CH; Steinhart, AH; Targownik, L; Williams, C | 1 |
Figueroa Corona, C; Flores Pérez, L; Ibáñez Lazo, P; Quera Pino, R; Sedano Muñoz, R | 1 |
Apostolopoulos, G; Axiaris, G; Banasa, M; Belesiotou, E; Dimas, I; Drygiannakis, I; Fragaki, M; Karmiris, K; Kouskoumpekou, F; Koutroubakis, IE; Mantzaris, GJ; Maraki, S; Michopoulos, S; Moschovis, D; Paspatis, G; Pontas, C; Prifti, H; Stamouli, V; Theocharis, G; Thomopoulos, K; Tsolias, C; Tzouvala, M; Viazis, N; Zampeli, E | 1 |
Akinci, H; Alkan, A; Coskun, Y; Hamamci, M; Kilincalp, S; Yuksel, I | 1 |
Li, Y; Liu, Q; Tang, JH; Wen, JJ; Zhu, JQ | 1 |
Cardenas-Vargas, E; Cid-Baez, MA; Delgado-Enciso, I; Flores-Morales, V; Garza-Veloz, I; Martinez-Fierro, ML; Ortiz-Castro, Y; Rocha-Pizaña, MR; Rodriguez-Sanchez, IP; Trejo-Vazquez, F; Villela-Ramirez, GA | 1 |
Ardizzone, S; Bezzio, C; Bosani, M; Carmagnola, S; Cassinotti, A; Chibbar, R; Dell'Era, A; Grillo, S; Landi, S; Maconi, G; Massari, A; Mezzina, N; Molteni, P; Pastorelli, L | 1 |
Casanova, MJ; Gisbert, JP; Rojo, E | 1 |
Abbass, M; Cepek, J; Feagan, BG; Jairath, V; Khanna, R; MacDonald, JK; Nguyen, TM; Parker, CE; Townsend, CM | 1 |
Dubois, E; Ferrante, M; Geelen, R; Moens, A; Sabino, J; Vermeire, S | 1 |
Bravo-Soto, GA; Candia, R; Hernandez, C; Monrroy, H; Nguyen, GC | 1 |
Diéguez Castillo, C; Hernández Martínez, Á; Lázaro Sáez, M; Moreno Moraleda, I | 1 |
Angelucci, E; Annese, V; Aratari, A; Biancone, L; Bossa, F; Cappello, M; Castiglione, F; Cottone, M; Di Mitri, R; Giunta, M; Kohn, A; Macaluso, FS; Mocciaro, F; Onali, S; Orlando, A; Papi, C; Renna, S; Rispo, A; Scimeca, D; Scribano, ML; Testa, A; Ventimiglia, M | 1 |
Bajor, J; Faluhelyi, N; Hegyi, P; Hegyi, PJ; Németh, BC; Szakács, Z | 1 |
Dias, E; Macedo, G; Santos-Antunes, J | 1 |
Hibi, T; Hisamatsu, T; Ikezaki, O; Kiyohara, H; Kobayashi, T; Kuronuma, S; Matsubayashi, M; Morikubo, H; Nakano, M; Okabayashi, S; Ozaki, R; Sagami, S; Shiba, T; Takeuchi, O; Tanaka, Y | 1 |
Beaufrère, A; Céruti, H; Coffin, B; Dussaux, C; Gervais, A; Guilbaud, L; Kayem, G; Maisonneuve, E; Mandelbrot, L | 1 |
Bi, Y; Corral, JE; Farraye, FA; Ji, B; Kröner, PT; Lukens, FJ; Montenegro, ML | 1 |
Barnhoorn, MC; de Boer, NK; Storm, BN; van der Voorn, MMPJA | 1 |
Almetwaly, SA; Elgamal, EE; Elshahat, OM; Mahgoob, RAS | 1 |
Abbas, A; Alhalabi, M; Ali, F; Eddin, KA | 1 |
Catapani, WR; Santos, RCFD; Takahashi, AAR; Waisberg, J | 1 |
Abbas, A; Alhalabi, M; Ali Deeb, S; Ali, F | 1 |
Choe, BH; Choi, S; Choi, SY; Choi, YJ; Hong, J; Hong, SJ; Jang, HJ; Kang, B; Kang, KS; Kang, Y; Kim, HJ; Kim, JY; Kim, SC; Kim, YB; Lee, K; Lee, KJ; Lee, YJ; Lee, YM; Park, JH; Yi, DY | 1 |
Bousvaros, A; Chan, C; Liu, E; Mansuri, I; Rufo, PA; Wang, S | 1 |
Basnet, BK; Bhandari, A | 1 |
76 review(s) available for azathioprine and mesalamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Sulfasalazine | 1992 |
Maintenance treatment for Crohn's disease: has the time arrived?
Topics: Aminosalicylic Acids; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine | 1992 |
[Conservative therapy of ulcerative colitis--long-term experience].
Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Prognosis; Sulfasalazine | 1991 |
Medical treatment of ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Adrenocorticotropic Hormone; Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Diet; Humans; Injections, Intravenous; Mesalamine; Physician's Role; Prednisolone; Sulfasalazine | 1984 |
[Crohn disease: prevention and drug therapy].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mesalamine; Pregnenediones; Recurrence | 1995 |
Maintenance of symptomatic remission in patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine | 1993 |
[Current medical treatment of hemorrhagic rectocolitis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Mesalamine; Sulfasalazine | 1994 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole | 1994 |
Medical therapies for inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Tumor Necrosis Factor-alpha | 1998 |
[Drug treatment of Crohn's disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Protocols; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methotrexate; Prednisone; Remission Induction; Treatment Outcome | 1998 |
The case against routine post-operative therapy for prevention of recurrence in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Digestive System Surgical Procedures; Humans; Mesalamine; Metronidazole; Postoperative Period; Prognosis; Randomized Controlled Trials as Topic; Secondary Prevention | 1998 |
New strategies in the management of inflammatory bowel disease.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Glucocorticoids; Humans; Immunity, Mucosal; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Prevalence; Tumor Necrosis Factor-alpha | 1999 |
[Recent progress in therapy of inflammatory bowel diseases].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids | 1999 |
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Cyclosporine; Humans; Hydroxyurea; Ileum; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Microscopy; Sulfasalazine; Time Factors | 1999 |
[Medical treatment of Crohn's disease].
Topics: Antibodies, Monoclonal; Azathioprine; CD4 Antigens; Crohn Disease; Enteral Nutrition; Heparin; Humans; Immunosuppressive Agents; Interleukin-10; Mesalamine; Metronidazole; Prednisolone; Tumor Necrosis Factor-alpha | 2000 |
Clinical pharmacology of inflammatory bowel disease therapies.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mesalamine; Methotrexate; Pharmacogenetics; Receptors, Glucocorticoid | 2000 |
Evolving treatment strategies for inflammatory bowel disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporins; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Methotrexate; Mycophenolic Acid; Steroids; Tacrolimus | 2001 |
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Availability; Budesonide; Catheterization; Electrodes; Humans; Hydrogen-Ion Concentration; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Reference Values; Telemetry | 2001 |
Conventional treatment of Crohn's disease: objectives and outcomes.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome | 2001 |
[Therapeutic principles for chronic inflammatory bowel disease].
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colectomy; Colitis; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Crohn Disease; Glucocorticoids; Humans; Mesalamine; Meta-Analysis as Topic; Prognosis; Quality of Life; Randomized Controlled Trials as Topic | 2001 |
Review article: maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Remission Induction | 2002 |
[Drug therapy of Crohn disease].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Secondary Prevention; Treatment Outcome | 2001 |
[Can the postoperative relapse of Crohn disease be influenced?].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Postoperative Complications; Recurrence | 2001 |
Conventional treatments for ankylosing spondylitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Azathioprine; Diphosphonates; Exercise Therapy; Gold; Humans; Mesalamine; Pain; Pamidronate; Patient Education as Topic; Physical Therapy Modalities; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2002 |
[Conservative therapy of inflammatory bowel diseases].
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Prednisolone; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2002 |
[Management of ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anemia; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antiviral Agents; Azathioprine; Budesonide; Clinical Trials as Topic; Colectomy; Colitis, Ulcerative; Colonic Pouches; Colonoscopy; Colorectal Neoplasms; Cyclosporins; Gastrointestinal Agents; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Injections, Intravenous; Interferons; Mercaptopurine; Mesalamine; Osteoporosis; Placebos; Practice Guidelines as Topic; Recurrence; Remission Induction; Risk Factors; Suppositories; Time Factors | 2003 |
[Treatment of Crohn's disease].
Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Case-Control Studies; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Metronidazole; Osteoporosis; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Ulcerative colitis: conservative management and long-term effects.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporins; Double-Blind Method; Follow-Up Studies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interferon-beta; Mercaptopurine; Mesalamine; Pilot Projects; Placebos; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Treatment Outcome | 2004 |
Review article: chronic active disease and maintaining remission in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chronic Disease; Crohn Disease; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Prognosis; Steroids; Thalidomide | 2004 |
[Guidelines for treatment of ulcerative colitis in children].
Topics: Azathioprine; Child; Colitis, Ulcerative; Contraindications; Cyclosporins; Growth Disorders; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Practice Guidelines as Topic; Prednisolone; Pulse Therapy, Drug; Quality of Life | 2005 |
[A case of simple ulcer with ulcerative colitis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Cecal Diseases; Colitis, Ulcerative; Diagnosis, Differential; Gastrointestinal Hemorrhage; Humans; Male; Mesalamine; Ulcer | 2005 |
Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature.
Topics: Adenocarcinoma; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Humans; Ileal Neoplasms; Incidence; Male; Mesalamine; Prognosis; Risk Factors; Sex Factors; Smoking; Time Factors | 2006 |
What's new: innovative concepts in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Randomized Controlled Trials as Topic; Steroids | 2006 |
Pharmacogenetics in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Sulfasalazine; Treatment Outcome | 2006 |
Conventional therapy for Crohn's disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Nutrition Therapy; Randomized Controlled Trials as Topic; Remission Induction | 2006 |
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Azathioprine; Cell Survival; Crohn Disease; Humans; Immunity, Mucosal; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-12; Interleukin-6; Intestinal Mucosa; Mesalamine; Signal Transduction; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2007 |
[Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
Topics: Algorithms; Anastomosis, Surgical; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Crohn Disease; Endoscopy; Female; Humans; Ileum; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Metronidazole; Odds Ratio; Randomized Controlled Trials as Topic; Risk; Risk Factors; Secondary Prevention; Smoking; Time Factors | 2006 |
[Medical therapy of inflammatory bowel diseases: Crohn's disease].
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Crohn Disease; Fistula; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Severity of Illness Index | 2007 |
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colorectal Neoplasms; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex | 2007 |
[Medical therapy of inflammatory bowel diseases: ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Severity of Illness Index | 2007 |
Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Enteral Nutrition; Fatty Acids, Omega-3; Humans; Infliximab; Mesalamine; Methotrexate; Natalizumab; Probiotics; Randomized Controlled Trials as Topic | 2008 |
Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Therapy; Colitis, Ulcerative; Cyclosporine; Forecasting; Humans; Immunosuppressive Agents; Mesalamine; Patient Satisfaction | 2008 |
Optimizing drug therapy in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Patient Compliance; Prednisone; Treatment Failure | 2007 |
[Treatment of Crohn's disease].
Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Colectomy; Combined Modality Therapy; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Methotrexate | 2009 |
Reproductive issues in inflammatory bowel disease.
Topics: Adaptation, Psychological; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Humans; Immunosuppressive Agents; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Pregnancy; Pregnancy Complications; Reproductive Behavior; Stress, Psychological; Sulfasalazine | 2009 |
[The problems of compliance and adherence, using the example of chronic inflammatory bowel disease].
Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Male; Mental Disorders; Mesalamine; Patient Compliance; Physician-Patient Relations; Risk Factors; Social Support | 2009 |
[For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Child; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Enteral Nutrition; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Meta-Analysis as Topic; Middle Aged; Prednisone; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors | 2009 |
The future of inflammatory bowel disease care.
Topics: Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials as Topic; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Natalizumab; Polyethylene Glycols; Tumor Necrosis Factor-alpha | 2009 |
Pancreatitis in inflammatory bowel diseases.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Pancreatitis; Sulfasalazine | 2010 |
Pharmacogenomics in the treatment of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Cytokines; Drug Monitoring; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Inosine Triphosphatase; Mesalamine; Methyltransferases; Pharmacogenetics; Pyrophosphatases; Receptors, Glucocorticoid; Sulfasalazine | 2010 |
[Postoperative recurrence of Crohn's disease, and its prevention].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Postoperative Period; Recurrence; Risk Factors | 2010 |
Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis.
Topics: Antibodies, Monoclonal; Azathioprine; Child; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cost-Benefit Analysis; Health Care Costs; Humans; Infliximab; Mesalamine; Models, Economic; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Standard of Care; Treatment Outcome | 2011 |
Current treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Endoscopy; Gastroenterology; Humans; Infliximab; Mercaptopurine; Mesalamine; Remission Induction; Steroids; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence.
Topics: Adalimumab; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Biomarkers; Capsule Endoscopy; Colonoscopy; Crohn Disease; Enteral Nutrition; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Imaging; Mesalamine; Secondary Prevention; Sulfasalazine; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Ultrasonography | 2012 |
Prevention of postoperative recurrence of Crohn's disease.
Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interleukin-10; Intestine, Small; Laparoscopy; Mercaptopurine; Mesalamine; Nitroimidazoles; Probiotics; Secondary Prevention; Treatment Outcome | 2012 |
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Butyric Acid; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Defensins; Extracellular Matrix; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Leptin; Matrix Metalloproteinases; Mesalamine; Paneth Cells; Probiotics; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfasalazine; Tumor Necrosis Factor-alpha; Wound Healing | 2012 |
An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based series.
Topics: Adolescent; Adult; Aged; Azathioprine; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Retrospective Studies; Young Adult | 2012 |
[Rational treatment of ulcerative colitis--local or systemic therapy? Surgery?].
Topics: Administration, Oral; Administration, Rectal; Adrenal Cortex Hormones; Algorithms; Anti-Inflammatory Agents; Azathioprine; Calcineurin Inhibitors; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppressive Agents; Infusions, Intravenous; Mesalamine; Proctocolectomy, Restorative; Remission Induction; Secondary Prevention; Tumor Necrosis Factor-alpha | 2012 |
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfasalazine | 2012 |
Strategies for the prevention of postoperative recurrence of Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colectomy; Colon; Colonoscopy; Crohn Disease; Humans; Ileum; Immunosuppressive Agents; Infliximab; Intestinal Perforation; Mercaptopurine; Mesalamine; Nitroimidazoles; Odds Ratio; Proportional Hazards Models; Risk Factors; Secondary Prevention; Smoking; Treatment Outcome | 2013 |
Treatment of ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha | 2014 |
Steroid use in Crohn's disease.
Topics: Adrenal Cortex Hormones; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha | 2014 |
Clinical management of inflammatory bowel disease in the organ recipient.
Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colorectal Neoplasms; End Stage Liver Disease; Graft Rejection; Heart Transplantation; Humans; Inflammatory Bowel Diseases; Kidney Transplantation; Liver Transplantation; Mesalamine; Risk Factors; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2014 |
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Secondary Prevention | 2014 |
New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
Topics: Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Congresses as Topic; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mesalamine; Methotrexate; Review Literature as Topic; Secondary Prevention | 2015 |
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfasalazine | 2016 |
Advances in Pediatric Inflammatory Bowel Disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus | 2016 |
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Topics: Adult; Antimetabolites; Azathioprine; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Sulfasalazine; Withholding Treatment | 2016 |
Epidemiologic and therapeutic aspects of refractory coeliac disease - a systematic review.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Celiac Disease; Cladribine; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Mesalamine; Prednisolone; Prevalence; Thioguanine | 2016 |
Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Withholding Treatment | 2019 |
Treatment of microscopic colitis: the role of budesonide and new alternatives for refractory patients.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antidiarrheals; Antimetabolites; Azathioprine; Biological Products; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Colitis, Microscopic; Diarrhea; Humans; Loperamide; Malabsorption Syndromes; Mesalamine; Methotrexate; Prednisolone; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2020 |
Adalimumab for maintenance of remission in Crohn's disease.
Topics: Adalimumab; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Drug Administration Schedule; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Middle Aged; Patient Dropouts; Placebos; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
Topics: Adalimumab; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Azathioprine; Bias; Cohort Studies; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Purines; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Secondary Prevention; Tumor Necrosis Factor-alpha | 2020 |
Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Pancreatitis; Azathioprine; Cholangitis, Sclerosing; Cholelithiasis; Colitis, Ulcerative; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Marijuana Use; Mesalamine; Pancreatic Neoplasms; Pancreatitis; Pancreatitis, Alcoholic; Pancreatitis, Chronic; Tumor Necrosis Factor Inhibitors | 2022 |
23 trial(s) available for azathioprine and mesalamine
Article | Year |
---|---|
[Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclosporins; Humans; Mesalamine; Metronidazole; Sulfasalazine | 1986 |
Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Crohn Disease; Drug Interactions; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Male; Mesalamine; Methyltransferases; Middle Aged; Sulfasalazine; Thionucleotides | 2002 |
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Postoperative Period; Prospective Studies; Secondary Prevention; Treatment Outcome | 2004 |
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Prednisolone; Prospective Studies; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2006 |
Steroid dependent ulcerative colitis: azathioprine use is finally "evidence-based".
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Mesalamine; Single-Blind Method; Steroids | 2006 |
Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic response.
Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Male; Mercaptopurine; Mesalamine; Middle Aged; Remission Induction; Treatment Failure; Treatment Outcome | 2006 |
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Female; Gene Frequency; Genotype; Guanine Nucleotides; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Phenotype; Postoperative Period; Prospective Studies; Thioguanine; Thionucleotides; Time Factors | 2007 |
Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colonoscopy; Crohn Disease; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Interleukin-1beta; Interleukin-6; Male; Mesalamine; Middle Aged; Pilot Projects; Postoperative Complications; Prognosis; Prospective Studies; Secondary Prevention; Tumor Necrosis Factor-alpha; Young Adult | 2009 |
Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.
Topics: Adult; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Ileum; Immunosuppressive Agents; Male; Medication Adherence; Mesalamine; Multivariate Analysis; Recurrence; Risk Factors | 2009 |
Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; B7-2 Antigen; CD40 Antigens; Colitis, Ulcerative; Colon; Dendritic Cells; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin-10; Interleukin-12 Subunit p40; Interleukin-13; Interleukin-6; Male; Mercaptopurine; Mesalamine; Middle Aged; Probiotics; Receptors, Pattern Recognition; Young Adult | 2010 |
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Azathioprine; Bifidobacterium; Colitis, Ulcerative; Combined Modality Therapy; Double-Blind Method; Female; Humans; Lactobacillus; Male; Mesalamine; Middle Aged; Patient Selection; Probiotics; Recurrence; Remission Induction; Severity of Illness Index; Streptococcus thermophilus; Treatment Outcome | 2010 |
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colonoscopy; Crohn Disease; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Methyltransferases; Middle Aged; Patient Selection; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Young Adult | 2010 |
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Prospective Studies | 2010 |
Individually tailored treatment of medication nonadherence.
Topics: Adolescent; Azathioprine; Child; Feasibility Studies; Female; Humans; Inflammatory Bowel Diseases; Interviews as Topic; Male; Medication Adherence; Mercaptopurine; Mesalamine; Patient Education as Topic; Pilot Projects; Precision Medicine; Surveys and Questionnaires; Treatment Outcome | 2011 |
Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease.
Topics: Adolescent; Adolescent Behavior; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behavior Therapy; Caregivers; Child; Drug Administration Schedule; Drug Combinations; Epidemiologic Methods; Family Therapy; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Medication Adherence; Mercaptopurine; Mesalamine; Middle Aged; Self Administration; United States | 2012 |
Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Pilot Projects; Postoperative Care; Secondary Prevention; Statistics, Nonparametric; Wound Healing; Young Adult | 2012 |
Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behavior Therapy; Child; Cost of Illness; Delivery of Health Care; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Medication Adherence; Mercaptopurine; Mesalamine; Ohio; Pilot Projects; Severity of Illness Index; Telemedicine; Treatment Outcome | 2013 |
Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients.
Topics: Adult; Azathioprine; Crohn Disease; Humans; Incidence; Kaplan-Meier Estimate; Mesalamine; Middle Aged; Patient Readmission | 2013 |
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Postoperative Period; Quality of Life; Secondary Prevention; Surveys and Questionnaires; Treatment Outcome | 2013 |
Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.
Topics: Adult; Azathioprine; Crohn Disease; Demography; Female; Humans; Ileocecal Valve; Intestinal Obstruction; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Recurrence; Smoking; Treatment Outcome; Young Adult | 2014 |
[Long-term adalimumab therapy in ulcerative colitis in clinical practice: result of the Hungarian multicenter prospective study].
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hungary; Male; Mesalamine; Middle Aged; Prospective Studies; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2016 |
Traditional Chinese medicine combination therapy for patients with steroid-dependent ulcerative colitis: study protocol for a randomized controlled trial.
Topics: Azathioprine; Clinical Protocols; Colitis, Ulcerative; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Mesalamine; Outcome Assessment, Health Care | 2017 |
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial.
Topics: Azathioprine; Crohn Disease; Double-Blind Method; Humans; Mesalamine; Recurrence | 2020 |
198 other study(ies) available for azathioprine and mesalamine
Article | Year |
---|---|
Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.
Topics: Administration, Oral; Administration, Rectal; Adult; Azathioprine; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged | 1996 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Topics: Arthritis, Rheumatoid; Chlortetracycline; Combinatorial Chemistry Techniques; Enzyme Inhibitors; Fluorescent Dyes; Hydrolases; Minocycline; Models, Biological; Molecular Structure; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Streptomycin; Tetracycline | 2008 |
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.
Topics: Animals; Azathioprine; Bacteriological Techniques; Cattle; Cattle Diseases; Colony Count, Microbial; Crohn Disease; Culture Media; Humans; Immunosuppressive Agents; Mercaptopurine; Microbial Sensitivity Tests; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Reagent Kits, Diagnostic | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Azathioprine reduces extravasation and neutrophil trafficking in immune complex-mediated inflammation in the rat colon.
Topics: Aminosalicylic Acids; Animals; Antigen-Antibody Complex; Azathioprine; Colitis; Evans Blue; Male; Mesalamine; Neutrophils; Peroxidase; Rats; Rats, Inbred Strains | 1991 |
[Crohn disease in childhood].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Child; Combined Modality Therapy; Crohn Disease; Cross-Sectional Studies; Diseases in Twins; Epithelium; Humans; Intestinal Mucosa; Mesalamine; Risk; Sulfasalazine | 1986 |
Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Binding, Competitive; Drug Interactions; Gallic Acid; Humans; Kinetics; Mercaptopurine; Mesalamine; Methylation; Methyltransferases; Pyridines; Recombinant Proteins; Substrate Specificity; Sulfapyridine; Sulfasalazine | 1995 |
Tumour-necrosis-factor antibody treatment in Crohn's disease.
Topics: Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Child; Crohn Disease; Female; Humans; Mesalamine; Prednisone; Tumor Necrosis Factor-alpha | 1993 |
Ileitis after colectomy for ulcerative colitis or carcinoma.
Topics: Adult; Aged; Aminosalicylic Acids; Azathioprine; Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Female; Humans; Ileitis; Ileum; Male; Mesalamine; Methotrexate; Middle Aged; Postoperative Complications | 1994 |
Cryptogenic fibrosing alveolitis predating ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Prednisone; Pulmonary Fibrosis; Time Factors | 1996 |
6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Steroids; Time Factors | 1996 |
Regional enteritis complicating malignant lymphoma.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; Betamethasone; Colitis; Crohn Disease; Diarrhea; Humans; Hyperplasia; Intestinal Neoplasms; Lymph Nodes; Lymphoma, Large-Cell, Anaplastic; Male; Melena; Mesalamine; Prednisone | 1996 |
Pancreatitis in patients with inflammatory bowel disease.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; Child; Disease Progression; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Pancreatitis; Retrospective Studies | 1997 |
Postoperative outcome of Crohn's disease in 30 children.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Crohn Disease; Female; Follow-Up Studies; Humans; Male; Mesalamine; Postoperative Care; Recurrence; Risk Factors; Treatment Outcome | 1998 |
A comparison of budesonide and mesalamine for active Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Immunosuppressive Agents; Mesalamine; Multicenter Studies as Topic; Prednisolone; Remission Induction | 1999 |
Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction.
Topics: Aminosalicylic Acids; Anti-Ulcer Agents; Antirheumatic Agents; Azathioprine; Drug Interactions; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Phenylhydrazines | 1999 |
[56-year-old patient with segmental florid colitis and colonic amyloidosis].
Topics: Amyloidosis; Azathioprine; Colitis; Colonic Diseases; Colonoscopy; Crohn Disease; Diagnosis, Differential; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Serum Amyloid A Protein | 1999 |
[Pregnancy outcome in inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prognosis; Surveys and Questionnaires | 1999 |
[Extra-intestinal manifestations and complications in chronic active ulcerative colitis in childhood and adolescence].
Topics: Adolescent; Azathioprine; Budesonide; Child; Colitis, Ulcerative; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Leg Ulcer; Male; Mesalamine; Prednisolone; Pyoderma Gangrenosum; Treatment Outcome | 1999 |
[Agranulocytosis and transitory immune deficiency after fetal exposure to azathioprine and mesalazine].
Topics: Adult; Agammaglobulinemia; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; CD4-CD8 Ratio; Crohn Disease; Female; Fetus; Humans; Immunosuppressive Agents; Male; Maternal-Fetal Exchange; Mesalamine; Pregnancy; Pregnancy Complications; Time Factors | 1999 |
Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Confidence Intervals; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Probability; Proportional Hazards Models; Recurrence; Remission Induction; Sex Factors; Time Factors | 1999 |
Balsalazide and azathioprine or 6-mercaptopurine.
Topics: Administration, Oral; Aminosalicylic Acids; Antimetabolites; Azathioprine; Drug Interactions; Humans; Inhibitory Concentration 50; Mercaptopurine; Mesalamine; Methyltransferases; Phenylhydrazines; Prodrugs | 1999 |
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Colectomy; Colon; Cyclosporine; Female; Flow Cytometry; Genes, MDR; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Lymphocytes; Male; Mesalamine; Methotrexate; Middle Aged; Reference Values; Treatment Failure | 2000 |
Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Drug Interactions; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine | 2000 |
[Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Mesalamine; Pancreatitis | 2000 |
[Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Pilot Projects; Prospective Studies; Secondary Prevention | 2000 |
[Collagenous colitis. A study of 11 cases].
Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Anemia; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Autoimmune Diseases; Azathioprine; Chronic Disease; Colitis; Collagen; Colonoscopy; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Mixed Connective Tissue Disease; Retrospective Studies; Serum Albumin; Spondylitis; Steroids; Sulfasalazine; Thyroiditis, Autoimmune; Treatment Outcome | 2001 |
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
Topics: Adult; Aminosalicylic Acids; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Binomial Distribution; Chromatography, High Pressure Liquid; Confidence Intervals; Drug Interactions; Female; Humans; Immunosuppressive Agents; Leukopenia; Male; Mercaptopurine; Mesalamine; Methyltransferases; Phenylhydrazines; Sulfasalazine; Thioguanine | 2001 |
Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Recurrence; Retrospective Studies | 2001 |
[Pancreatic involvement in inflammatory bowel diseases in children].
Topics: Adolescent; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Pancreatitis; Retrospective Studies; Sulfasalazine | 2002 |
Ileal Crohn's disease is best treated by surgery.
Topics: Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Ileum; Mesalamine; Prednisolone | 2002 |
[Treatment of steroid-refractory ulcerative colitis with infliximab].
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Blood Transfusion; Budesonide; Colitis, Ulcerative; Drug Resistance; Drug Therapy, Combination; Enteral Nutrition; Female; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methylprednisolone; Prednisone; Remission Induction; Tumor Necrosis Factor-alpha | 2003 |
[Acute episode].
Topics: Acute Disease; Adult; Age Factors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Child; Controlled Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Nutritional Physiological Phenomena; Prednisolone; Time Factors | 2003 |
[Maintaining a remission].
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Methotrexate; Placebos; Postoperative Care; Prednisolone; Pregnancy; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Time Factors | 2003 |
Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Intestinal Fistula; Male; Medical Records; Mercaptopurine; Mesalamine; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome | 2003 |
Acute pancreatitis after long-term therapy with mesalazine, and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Hyperamylasemia; Male; Mesalamine; Pancreatitis; Time Factors | 2003 |
Are drugs a risk factor of post-ERCP pancreatitis?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Cholangiopancreatography, Endoscopic Retrograde; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Humans; Male; Mesalamine; Middle Aged; Morphine Derivatives; Multivariate Analysis; Pancreatitis; Prednisone; Retrospective Studies; Risk Factors; Valproic Acid | 2003 |
Clinical features and management of Crohn's disease in Chinese patients.
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Child; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Male; Mesalamine; Middle Aged; Prednisone; Sulfasalazine; Ultrasonography | 2004 |
Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays.
Topics: Adult; Aged; Azathioprine; Caco-2 Cells; Colitis, Ulcerative; Colon; Crohn Disease; DNA Primers; Female; Gastrointestinal Agents; Gene Expression Profiling; Genetic Markers; Humans; Male; Mesalamine; Middle Aged; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2004 |
[New research results give hope. Causal therapy of Crohn disease in sight].
Topics: Algorithms; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Defensins; Humans; Immunosuppressive Agents; Mesalamine; Prednisolone; Prognosis; Time Factors; Trichuris | 2004 |
[Ulcerative colitis. Acute episode].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2004 |
[Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Postoperative Complications; Postoperative Period; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2004 |
Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colectomy; Colitis, Ulcerative; Denmark; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Mesalamine; Middle Aged; Neoplasms; Population Surveillance; Registries; Risk Assessment | 2004 |
Crohn's disease over 20 years after diagnosis in a referral population.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; France; Health Status; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Male; Mesalamine; Methotrexate; Middle Aged; Multivariate Analysis; Parenteral Nutrition, Home; Quality of Life; Recurrence; Reoperation; Retrospective Studies; Surveys and Questionnaires | 2004 |
[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Immunosuppressive Agents; Mesalamine; Recurrence; Risk Factors; Time Factors; Ursodeoxycholic Acid | 2005 |
Distal adenomatous polyps are rare in patients with inflammatory bowel disease.
Topics: Adenomatous Polyps; Antimetabolites, Antineoplastic; Azathioprine; Case-Control Studies; Colorectal Neoplasms; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Retrospective Studies; Risk Factors | 2006 |
Azathioprine versus mesalamine in steroid-dependent ulcerative colitis: long-awaited results?
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Mesalamine; Steroids; Treatment Outcome | 2006 |
Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Combined Modality Therapy; Crohn Disease; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mesalamine; Prednisone | 2006 |
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Mercaptopurine; Mesalamine | 2006 |
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Child; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Remission Induction; Retrospective Studies; Severity of Illness Index; Thioguanine; Treatment Outcome | 2006 |
[Infliximab-induced hepatitis in a patient with Crohn's disease].
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Azathioprine; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mesalamine; Methotrexate; Pancreatitis; Prednisone; Rectovaginal Fistula | 2006 |
Inflammatory bowel disease in Thai children: presentations and outcomes of treatment.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Intestinal Fistula; Intestine, Small; Male; Mesalamine; Thailand; Treatment Outcome | 2006 |
Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention | 2006 |
Medication-taking behavior in a cohort of patients with inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Patient Compliance; Prospective Studies; Self Medication; Surveys and Questionnaires | 2006 |
Severe adverse reactions to Infliximab therapy are common in young children with inflammatory bowel disease.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Child, Preschool; Drug Hypersensitivity; Female; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Retrospective Studies | 2007 |
Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bacteria; Bacterial Adhesion; Colitis; Colitis, Ulcerative; Colon; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mesalamine; Middle Aged | 2007 |
Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Crohn Disease; Cross-Sectional Studies; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Prevalence; Treatment Refusal | 2007 |
[News from the Cochrane Library: Maintenance of remission in ulcerative colitis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Germany; Humans; Immunosuppressive Agents; Mesalamine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Remission Induction; Treatment Outcome | 2007 |
Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?
Topics: Adult; Aged; Azathioprine; Budesonide; Canada; Crohn Disease; Cross-Sectional Studies; Decision Support Techniques; Fees, Pharmaceutical; Female; Fish Oils; Focus Groups; Gastrointestinal Agents; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Patient Satisfaction; Postoperative Care; Regression Analysis; Reproducibility of Results; Secondary Prevention | 2008 |
Outcome of childhood ulcerative colitis at 2 years.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Growth; Hospitalization; Humans; Immunosuppressive Agents; Male; Mesalamine | 2007 |
Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Medical Audit; Mesalamine; Methyltransferases; Recurrence; Retrospective Studies; Treatment Outcome | 2008 |
Medication adherence and quality of life in pediatric inflammatory bowel disease.
Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guanine Nucleotides; Humans; Illness Behavior; Male; Medication Adherence; Mercaptopurine; Mesalamine; Quality of Life; Thionucleotides | 2008 |
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child, Preschool; Colitis, Ulcerative; Drug Interactions; Drug Therapy, Combination; Humans; Mesalamine; Patient Compliance; Recurrence | 2008 |
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Topics: Acute Disease; Adult; Antimetabolites; Azathioprine; Cohort Studies; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Pancreatitis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Treatment of inflammatory bowel disease: a role for hypnotherapy?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Female; Humans; Hypnosis; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Quality of Life; Secondary Prevention; Suggestion; Young Adult | 2008 |
Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Body Height; Body Mass Index; Body Weight; Case-Control Studies; Child; Crohn Disease; Eating; Energy Metabolism; Follow-Up Studies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Nutritional Status; Retrospective Studies; Tumor Necrosis Factor-alpha | 2009 |
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome | 2008 |
Co-prescribing azathiopurine or 6-mercaptopurine and 5-aminosalicylate compounds in ulcerative colitis.
Topics: Adult; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Practice Patterns, Physicians'; Treatment Outcome | 2009 |
Association of idiopathic inflammatory myopathy and Crohn's disease.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intervertebral Disc Displacement; Lumbar Vertebrae; Magnetic Resonance Imaging; Mesalamine; Polymyositis; Treatment Outcome | 2009 |
Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Neoplasms; Lymphoma, T-Cell; Male; Mesalamine; Prognosis; Splenic Neoplasms; Young Adult | 2009 |
[Relapse rates of ulcerative colitis in remission and factors related to relapse].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Chronic Disease; Colitis, Ulcerative; Data Interpretation, Statistical; Female; Follow-Up Studies; Hemoglobins; Humans; Male; Mesalamine; Middle Aged; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Time Factors | 2008 |
[Relapse of ulcerative colitis in remission].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Chronic Disease; Colitis, Ulcerative; Hemoglobins; Humans; Mesalamine; Recurrence; Risk Factors | 2008 |
[Crohn's disease in association with IgA nephropathy].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Blood Pressure; Calcium Channel Blockers; Colonoscopy; Crohn Disease; Glomerulonephritis, IGA; Humans; Male; Mesalamine; Proteinuria | 2008 |
[A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Colonoscopy; Female; Humans; Mesalamine; Pancreatitis; Sulfasalazine; Tomography, X-Ray Computed; Young Adult | 2008 |
Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Antimetabolites; Azathioprine; China; Drug Therapy, Combination; Female; Genotype; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Methyltransferases; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Steroids | 2009 |
Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholestasis, Intrahepatic; Colitis, Ulcerative; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Mesalamine; Middle Aged | 2009 |
Medical therapy of IBD in 2009.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Natalizumab; Probiotics; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Secondary Prevention | 2009 |
Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; DNA; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Prospective Studies; Young Adult | 2009 |
Course of inflammatory bowel disease in patients infected with human immunodeficiency virus.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiretroviral Therapy, Highly Active; Azathioprine; CD4 Lymphocyte Count; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; HIV Infections; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Multivariate Analysis; Recurrence; Risk Factors | 2010 |
Barriers to oral medication adherence for adolescents with inflammatory bowel disease.
Topics: Administration, Oral; Adolescent; Azathioprine; Family; Female; Humans; Inflammatory Bowel Diseases; Male; Medication Adherence; Mesalamine; Severity of Illness Index | 2010 |
Inflammatory bowel disease in young people: the case for transitional clinics.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Azathioprine; Case-Control Studies; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Radiation Injuries; Retrospective Studies; Young Adult | 2010 |
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Steroids; Treatment Outcome | 2010 |
Health-related quality of life of youth with inflammatory bowel disease: a comparison with published data using the PedsQL 4.0 generic core scales.
Topics: Adolescent; Adult; Child; Female; Humans; Inflammatory Bowel Diseases; Interpersonal Relations; Male; Mercaptopurine; Mesalamine; Methylthioinosine; Middle Aged; Parents; Quality of Life; Self Concept; Severity of Illness Index; Sickness Impact Profile; Social Adjustment; Thioguanine | 2010 |
Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interviews as Topic; Male; Medication Adherence; Mercaptopurine; Mesalamine; Severity of Illness Index; Social Environment | 2010 |
Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Colchicine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intestinal Diseases; Korea; Male; Mesalamine; Middle Aged; Prognosis; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Ulcer; Young Adult | 2010 |
Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Topics: Azathioprine; Biomarkers, Tumor; Chromosomal Instability; Colitis, Ulcerative; Colon; Colonic Neoplasms; Crohn Disease; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Mesalamine; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shelterin Complex; T-Lymphocytes; Telomere; Telomere-Binding Proteins; Telomeric Repeat Binding Protein 1; Telomeric Repeat Binding Protein 2 | 2010 |
Ulcerative colitis in Madrid, Spain: current management.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colectomy; Colitis, Ulcerative; Female; Hospitals, Urban; Humans; Immunosuppressive Agents; Incidence; Male; Mesalamine; Middle Aged; Prognosis; Spain; Young Adult | 2010 |
Thiopurine S-methyltransferase deficiency associated with a novel mutation.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Benzazepines; Crohn Disease; Heterozygote; Humans; Male; Mesalamine; Methyltransferases; Mutation; Neutrophils; Nicotinic Agonists; Prednisolone; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2010 |
Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
Topics: Acute Disease; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Drug Hypersensitivity; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Prednisolone; Treatment Outcome | 2010 |
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Practice Guidelines as Topic; Prednisolone; Remission Induction | 2010 |
High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.
Topics: Adolescent; Aminosalicylic Acids; Azathioprine; Biotransformation; Child; Child, Preschool; Drug Therapy, Combination; Erythrocytes; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphopenia; Male; Mesalamine; Purines; Salicylates; Sulfasalazine | 2010 |
Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Aorta, Abdominal; Aortitis; Azathioprine; Crohn Disease; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Angiography; Mesalamine; Methotrexate; Methylprednisolone; Takayasu Arteritis; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Efficacy of early treatment with infliximab in pediatric Crohn's disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Humans; Infliximab; Korea; Male; Mesalamine; Prednisolone; Retrospective Studies; Secondary Prevention; Tumor Necrosis Factor-alpha | 2010 |
Incidence, severity, and etiology of drug-induced acute pancreatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Child, Preschool; Crohn Disease; Cytarabine; Dexamethasone; Female; Humans; Immunosuppressive Agents; Incidence; Male; Mesalamine; Middle Aged; Mycophenolic Acid; Pancreatitis; Ramipril; Retrospective Studies; Risk Factors; Severity of Illness Index; Valproic Acid; Young Adult | 2010 |
Pyodermatitis-pyostomatitis vegetans after subtotal colectomy for ulcerative colitis.
Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Diagnosis, Differential; Female; Humans; Mesalamine; Middle Aged; Prednisolone; Pyoderma; Recurrence; Stomatitis; Treatment Outcome | 2010 |
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Research Design; Secondary Prevention | 2010 |
Opportunistic streptococcal gastritis in a patient with ulcerative colitis mimicking gastric involvement by inflammatory bowel disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Azathioprine; Breath Tests; Colitis, Ulcerative; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastritis; Humans; Mesalamine; Opportunistic Infections; Pantoprazole; Prognosis; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Listeriosis; Mesalamine; Middle Aged; Tumor Necrosis Factor-alpha | 2010 |
Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Medication Adherence; Mesalamine; Middle Aged; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Self Report; Severity of Illness Index; Young Adult | 2010 |
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Treatment Outcome | 2011 |
Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Research Design; Secondary Prevention | 2011 |
VSL#3 and remission in active ulcerative colitis: larger studies required.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bifidobacterium; Colitis, Ulcerative; Diet; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lactobacillus; Mesalamine; Methotrexate; Probiotics; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Severity of Illness Index | 2011 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colorectal Neoplasms; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Proportional Hazards Models; Risk | 2012 |
Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Cells, Cultured; Colitis, Ulcerative; Crohn Disease; Female; HLA-G Antigens; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Mesalamine; Middle Aged | 2011 |
[Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Combined Modality Therapy; Crohn Disease; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Interleukin-12 Subunit p40; Mesalamine; Phototherapy; Psoriasis; Tumor Necrosis Factor-alpha; Ustekinumab | 2011 |
Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Denmark; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Mercaptopurine; Mesalamine; Remission Induction; Time Factors; Treatment Outcome | 2011 |
On the cost-effectiveness of the use of probiotics in inflammatory bowel disease.
Topics: Antibodies, Monoclonal; Azathioprine; Colectomy; Colitis, Ulcerative; Humans; Infliximab; Mesalamine | 2011 |
[Crohn's disease presenting with erythema nodosum as an early sign: a case report].
Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Colonoscopy; Crohn Disease; Erythema Nodosum; Female; Humans; Mesalamine; Prednisolone; Skin | 2011 |
Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Cost-Benefit Analysis; Crohn Disease; Decision Trees; Health Care Costs; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Monte Carlo Method; Postoperative Period; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Secondary Prevention | 2012 |
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine | 2011 |
Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.
Topics: Adult; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Mesalamine; Prognosis; Prospective Studies; Referral and Consultation; Tumor Necrosis Factor-alpha; Young Adult | 2012 |
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chi-Square Distribution; Cohort Studies; Crohn Disease; Female; Gastrointestinal Agents; Humans; Hungary; Immunosuppressive Agents; Incidence; Infliximab; Logistic Models; Male; Mercaptopurine; Mesalamine; Methotrexate; Phenotype; Proportional Hazards Models; Retrospective Studies; Steroids; Sulfasalazine; Surveys and Questionnaires | 2012 |
[FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Diagnosis, Differential; General Practice; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Prognosis | 2011 |
[Guidelines for the management of ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Humans; Hydrocortisone; Infliximab; Injections, Intravenous; Mesalamine; Methylprednisolone; Severity of Illness Index; Sulfasalazine | 2012 |
[Guidelines for the management of Crohn's disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2012 |
Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
Topics: Abscess; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Anus Diseases; Azathioprine; Ciprofloxacin; Crohn Disease; Cutaneous Fistula; Endosonography; Female; Humans; Immunosuppressive Agents; Incidental Findings; Infliximab; Male; Mercaptopurine; Mesalamine; Metronidazole; Middle Aged; Rectal Fistula; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult | 2012 |
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Endoscopy, Gastrointestinal; Humans; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Mercaptopurine; Mesalamine; Methotrexate; Treatment Outcome | 2012 |
[The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cohort Studies; Colectomy; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Hungary; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Time Factors; Treatment Failure | 2012 |
The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Azathioprine; Bone Marrow; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Prospective Studies; Retrospective Studies; Thionucleotides; Young Adult | 2012 |
Resource utilization during pediatric to adult transfer of care in IBD.
Topics: Adolescent; Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Emergency Service, Hospital; Endoscopy, Gastrointestinal; Female; Gastrostomy; Health Resources; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Laparoscopy; Male; Mesalamine; Patient Compliance; Retrospective Studies; Severity of Illness Index; Transition to Adult Care | 2013 |
"In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease.
Topics: Adalimumab; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Azathioprine; Budesonide; Cells, Cultured; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Interferon-gamma; Interleukin-10; Male; Mesalamine; Middle Aged; Retrospective Studies; T-Lymphocytes; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
[Chemoprevention of colorectal cancer associated with IBD].
Topics: Azathioprine; Colorectal Neoplasms; Crohn Disease; Folic Acid; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine | 2012 |
Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; China; Drug Interactions; Drug Monitoring; Female; Follow-Up Studies; Genetic Association Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukopenia; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Mutation; Prospective Studies; Young Adult | 2012 |
Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Middle Aged; Retrospective Studies; Steroids; Treatment Outcome | 2013 |
[A case of squamous cell carcinoma of the breast in a patient with Crohn's disease taking azathioprine].
Topics: Adult; Azathioprine; Breast Neoplasms; Carcinoma, Squamous Cell; Colonoscopy; Combined Modality Therapy; Crohn Disease; Female; Humans; Immunosuppressive Agents; Mesalamine; Positron-Emission Tomography | 2012 |
Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Case-Control Studies; DNA, Viral; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Middle Aged; Portugal; Prevalence; Prognosis; Prospective Studies; Risk Factors | 2013 |
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Resistance; Drug Substitution; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, B-Cell, Marginal Zone; Mesalamine; Methylprednisolone; Rectovaginal Fistula; Recurrence; Remission Induction; Stomach Neoplasms | 2014 |
Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Denmark; Digestive System Surgical Procedures; Drug Utilization; Female; Glucocorticoids; Humans; Male; Mesalamine; Middle Aged; Risk Factors; Survival Analysis; Young Adult | 2014 |
Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Azathioprine; Congenital Abnormalities; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Logistic Models; Mercaptopurine; Mesalamine; Middle Aged; Odds Ratio; Pregnancy; Pregnancy Complications; Retrospective Studies; Risk Factors; Severity of Illness Index; United Kingdom; Young Adult | 2014 |
IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Female; Gastrointestinal Agents; Genetic Predisposition to Disease; Humans; Infliximab; Male; Mesalamine; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Portugal; Receptors, Interleukin; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Differences in the management of pediatric and adult onset ulcerative colitis--lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis.
Topics: Adult; Age of Onset; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Practice Guidelines as Topic | 2014 |
Effect of inflammatory bowel disease therapies on immunogenicity of Mycobacterium paratuberculosis proteins.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibodies, Monoclonal; Azathioprine; Bacterial Proteins; Budesonide; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Middle Aged; Mycobacterium avium subsp. paratuberculosis; Prednisone; Protein Tyrosine Phosphatases; Young Adult | 2014 |
Ileorectal anastomosis in comparison with ileal pouch anal anastomosis in reconstructive surgery for ulcerative colitis--a single institution experience.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adolescent; Adrenal Cortex Hormones; Adult; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colonic Pouches; Female; Follow-Up Studies; Humans; Ileum; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Pouchitis; Proctitis; Proctocolectomy, Restorative; Rectal Neoplasms; Rectum; Retrospective Studies; Risk Factors; Young Adult | 2014 |
Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis.
Topics: Adenomatous Polyposis Coli; Age of Onset; Anti-Infective Agents; Azathioprine; beta Catenin; Biomarkers; Cells, Cultured; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Female; Fibroblasts; Gastrointestinal Agents; Genetic Predisposition to Disease; Hamartoma Syndrome, Multiple; Heredity; Humans; Infant; Interleukin-10 Receptor alpha Subunit; Interleukin-10 Receptor beta Subunit; Intestinal Mucosa; Male; Mesalamine; Pedigree; Phenotype; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; RNA, Messenger | 2013 |
Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colitis, Ulcerative; Drug Therapy, Combination; Enema; Female; Humans; Hyaluronic Acid; Immunosuppressive Agents; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Pilot Projects; Prospective Studies; Remission Induction; Sigmoidoscopy; Treatment Outcome; Young Adult | 2014 |
Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study.
Topics: Adolescent; Adult; Azathioprine; Case-Control Studies; Crohn Disease; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Humans; Male; Mesalamine; Moraceae; Recurrence; Retrospective Studies; Young Adult | 2014 |
[A case of IgG4-related sclerosing mesenteritis associated with Crohn's disease].
Topics: Anti-Inflammatory Agents; Appendix; Azathioprine; Colonoscopy; Crohn Disease; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Mesalamine; Middle Aged; Panniculitis, Peritoneal; Prednisolone; Tomography, X-Ray Computed; Ultrasonography; Urinary Bladder | 2014 |
Clinical features and course of ulcerative colitis diagnosed in asymptomatic subjects.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Azathioprine; Colitis, Ulcerative; Colonoscopy; Disease Progression; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidental Findings; Male; Mesalamine; Middle Aged; Proctitis; Prognosis; Retrospective Studies | 2014 |
[Postoperative recurrence: adalimumab is an effective standard medication].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine | 2014 |
New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid.
Topics: Adult; Amino Acid Transport Systems; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cells, Cultured; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Markers; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphocytes; Male; Mesalamine; Middle Aged; Polymorphism, Single Nucleotide | 2014 |
The young patient with acute bloody diarrhoea.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; C-Reactive Protein; Colitis, Ulcerative; Diagnosis, Differential; Diarrhea; Fluid Therapy; Gastroenteritis; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Sigmoidoscopy | 2014 |
Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Odds Ratio; Pancreatitis; Tumor Necrosis Factor-alpha; United States; United States Food and Drug Administration; Young Adult | 2014 |
Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Colonoscopy; Eosinophilia; Female; Humans; Immunosuppressive Agents; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.
Topics: Absorptiometry, Photon; Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium, Dietary; Cohort Studies; Drug Therapy, Combination; Female; Femur; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Lumbar Vertebrae; Male; Mesalamine; Middle Aged; Osteoporosis; Tumor Necrosis Factor-alpha; Vitamin D; Young Adult | 2014 |
Indian Society of Gastroenterology consensus statements on Crohn's disease in India.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Gastroenterology; Glucocorticoids; Humans; Immunosuppressive Agents; India; Infliximab; Maintenance Chemotherapy; Mesalamine; Remission Induction; Societies, Medical | 2015 |
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
Topics: Adolescent; Anti-Inflammatory Agents; Arylamine N-Acetyltransferase; Azathioprine; Biotransformation; Child; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Genotype; Humans; Isoenzymes; Male; Mercaptopurine; Mesalamine; Pharmacogenetics; Phenotype; Pilot Projects; Polymorphism, Genetic; Retrospective Studies; Time Factors; Treatment Outcome | 2015 |
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Cell Line, Tumor; Hepatocytes; Humans; Mercaptopurine; Mesalamine | 2015 |
[What therapy for which patient?].
Topics: Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Precision Medicine | 2015 |
Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Genotype; Guanine Nucleotides; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukopenia; Male; Mesalamine; Methyltransferases; Polymorphism, Genetic; Retrospective Studies; Thionucleotides | 2015 |
Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report.
Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Crohn Disease; Disease Progression; Gerstmann Syndrome; Humans; Magnetic Resonance Imaging; Male; Mesalamine; Middle Aged; Prednisolone; Vasculitis, Central Nervous System | 2015 |
Editorial: preventing disease progression in Crohn's--can we shut the stable door before the horse bolts?
Topics: Animals; Azathioprine; Crohn Disease; Disease Progression; Humans; Immunologic Factors; Mesalamine; Secondary Prevention; Tumor Necrosis Factor-alpha | 2015 |
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.
Topics: Adrenomedullin; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Pilot Projects; Prednisolone; Prospective Studies; Tacrolimus; Treatment Outcome; Vasodilator Agents | 2016 |
Thromboembolism as an important complication of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis | 2016 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?
Topics: Adolescent; Adult; Aged; Attitude of Health Personnel; Azathioprine; Female; Focus Groups; Gastroenterologists; Health Knowledge, Attitudes, Practice; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Qualitative Research; Quality of Life; Switzerland; Young Adult | 2016 |
Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colonoscopy; Disease Progression; Female; Humans; Intestinal Mucosa; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Proportional Hazards Models; Recurrence; Republic of Korea; Retrospective Studies; Severity of Illness Index; Wound Healing; Young Adult | 2016 |
Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?
Topics: Acidobacteria; Actinobacteria; Adult; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Azathioprine; Bacteroidetes; Case-Control Studies; Crohn Disease; DNA, Ribosomal; Dysbiosis; Feces; Female; Firmicutes; Fusobacteria; Gammaproteobacteria; Gastrointestinal Agents; Gastrointestinal Microbiome; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Mesalamine; Prednisolone; Proteobacteria; Republic of Korea; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sequence Analysis, RNA; Tumor Necrosis Factor-alpha | 2016 |
Confocal laser endomicroscopy in ulcerative colitis: a longitudinal study of endomicroscopic changes and response to medical therapy (with videos).
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Case-Control Studies; Colitis, Ulcerative; Colonoscopy; Female; Fluorescein; Fluorescent Dyes; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Intravital Microscopy; Longitudinal Studies; Male; Mesalamine; Microscopy, Confocal; Middle Aged; Recurrence; Treatment Outcome; Young Adult | 2016 |
[Not a cure, but a normal life].
Topics: Azathioprine; Biological Products; Budesonide; Cell Adhesion Molecules; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mesalamine; Tumor Necrosis Factor-alpha | 2016 |
Ocular Toxoplasmosis Reactivation in a Patient With Inflammatory Bowel Disease Under Treatment With Azathioprine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chorioretinitis; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Mesalamine; Recurrence; Toxoplasmosis, Ocular | 2016 |
Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn's Disease Under Combined Immunosuppression: Escalation versus Early Treatment.
Topics: Adolescent; Azathioprine; Child; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Mesalamine; Prospective Studies; Treatment Outcome | 2016 |
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Topics: Adrenal Cortex Hormones; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Female; Follow-Up Studies; France; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Intestinal Neoplasms; Lymphoproliferative Disorders; Male; Mesalamine; Methotrexate; Middle Aged; Myeloproliferative Disorders; Neoplasms; Proportional Hazards Models; Protective Factors; Registries; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Successful colonoscopic fecal microbiota transplantation for active ulcerative colitis: First report from India.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Colitis, Ulcerative; Colonoscopy; Fecal Microbiota Transplantation; Humans; India; Male; Mesalamine; Remission Induction; Treatment Failure; Treatment Outcome | 2016 |
A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Azathioprine; Cardiac Imaging Techniques; Colitis, Ulcerative; Fever; Heart Failure; Humans; Hypotension; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mercaptopurine; Mesalamine; Middle Aged; Myocarditis | 2016 |
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colonoscopy; Crohn Disease; Disease Progression; Female; Humans; Immunosuppressive Agents; Intestines; Italy; Magnetic Resonance Imaging; Male; Mesalamine; Middle Aged; Retrospective Studies; Severity of Illness Index; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Demyelinating Diseases; Drug Substitution; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Infliximab; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Mortality; Narcotics; Prednisone; Prospective Studies; Registries; Risk Factors; Sulfasalazine; Time Factors; Young Adult | 2017 |
Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case.
Topics: Acute Disease; Age of Onset; Azathioprine; Colitis, Ulcerative; Humans; Infliximab; Intestinal Mucosa; Male; Mesalamine; Middle Aged | 2017 |
Chronic paracoccidioidmycosis in a woman with Crohn Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Crohn Disease; Female; Gingival Diseases; Humans; Immunosuppressive Agents; Mesalamine; Middle Aged; Paracoccidioidomycosis | 2017 |
Cutaneous side effects caused by treatment for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Drug Eruptions; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Tumor Necrosis Factor-alpha | 2016 |
Long-term maintenance treatment of ulcerative colitis in eastern India: a 15-year follow-up.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; India; Maintenance Chemotherapy; Male; Mesalamine; Middle Aged; Prospective Studies; Recurrence; Young Adult | 2018 |
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
Topics: Alopecia; Antibodies, Monoclonal; Azathioprine; Biomarkers, Pharmacological; Genetic Predisposition to Disease; Genome-Wide Association Study; Genomic Structural Variation; Haplotypes; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Japan; Leukopenia; Logistic Models; Mercaptopurine; Mesalamine; Pharmacogenetics; Pyrophosphatases; Retrospective Studies; Risk; ROC Curve; Sulfasalazine | 2018 |
The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Middle Aged; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2018 |
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Mesalamine; Middle Aged; Mortality; Proportional Hazards Models; Protective Factors; Registries; Sweden; Ursodeoxycholic Acid | 2019 |
Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis; Epithelial Cells; Inflammation; Inflammatory Bowel Diseases; Intestines; Mesalamine; Mice; Wound Healing | 2019 |
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Canada; Crohn Disease; Gastroenterology; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Methotrexate; Prednisolone; Societies, Medical; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2019 |
Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bacterial Proteins; Bacterial Toxins; Case-Control Studies; Clostridium Infections; Diarrhea; Enterotoxins; Feces; Female; Glutamate Dehydrogenase; Greece; Hospitalization; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Diagnostic accuracy of intestinal ultrasound and magnetic resonance enterography for the detection of endoscopy-based disease activity in ileocolonic Crohn's disease.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Colonoscopy; Crohn Disease; Diagnostic Techniques, Digestive System; Female; Humans; Ileum; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mesalamine; Mesentery; Middle Aged; Prospective Studies; Sensitivity and Specificity; Ultrasonography; Young Adult | 2019 |
Regulatory mechanism of mesalazine on TLR4/MyD88-dependent pathway in mouse ulcerative colitis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colon; Disease Models, Animal; Down-Regulation; Ethanol; Humans; Intestinal Mucosa; Male; Mesalamine; Mice; MicroRNAs; Myeloid Differentiation Factor 88; Signal Transduction; Specific Pathogen-Free Organisms; Toll-Like Receptor 4; Trinitrobenzenesulfonic Acid; Up-Regulation | 2019 |
Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Becaplermin; Biomarkers; Case-Control Studies; Chemokine CXCL10; Chemokines; Cytokines; Female; Granulocyte Colony-Stimulating Factor; Humans; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Interleukin-6; Male; Mesalamine; Middle Aged; Receptors, Interleukin-1 | 2019 |
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis: A real-life experience.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Colitis, Ulcerative; Dosage Forms; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Italy; Logistic Models; Male; Mesalamine; Middle Aged; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2019 |
Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biological Factors; Colitis, Ulcerative; Drug Resistance; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Intestinal Mucosa; Mesalamine; Proctitis; Proctoscopy; Rectum; Treatment Outcome | 2020 |
Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link?
Topics: Adenocarcinoma; Adult; Age of Onset; Anti-Inflammatory Agents; Azathioprine; Breast Neoplasms; Colitis, Ulcerative; Colonic Neoplasms; Colorectal Neoplasms; Female; Genes, BRCA1; Genetic Predisposition to Disease; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Neoplastic Syndromes, Hereditary; Proctocolectomy, Restorative | 2021 |
Recurrent acute pancreatitis induced by 5-ASA and azathioprine in ulcerative colitis.
Topics: Acute Disease; Adult; Azathioprine; Colitis, Ulcerative; Humans; Male; Mesalamine; Pancreatitis; Recurrence | 2020 |
A case of severe diverticulosis in a patient with ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colonoscopy; Diverticulum; Female; Humans; Mesalamine; Middle Aged | 2021 |
Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S-methyltransferase inhibition.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Methyltransferases; Prospective Studies | 2021 |
Intrahepatic cholestasis of pregnancy associated with azathioprine: A case series.
Topics: Adult; Azathioprine; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Colitis, Ulcerative; Crohn Disease; Drug Substitution; Female; France; Humans; Immunosuppressive Agents; Mesalamine; Pregnancy; Pregnancy Complications; Pruritus; Remission, Spontaneous; Retrospective Studies; Ursodeoxycholic Acid; Withholding Treatment | 2021 |
Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound.
Topics: Azathioprine; Drug Substitution; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine | 2021 |
Comparative study between the efficacies of azathioprine and mesalazine in the treatment of severe alopecia areata.
Topics: Alopecia Areata; Azathioprine; Hair; Humans; Mesalamine; Treatment Outcome | 2022 |
SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.
Topics: Adult; Azathioprine; Colitis, Ulcerative; COVID-19; COVID-19 Drug Treatment; Humans; Infliximab; Male; Mesalamine; Patient Safety; SARS-CoV-2; Time Factors; Tumor Necrosis Factor Inhibitors | 2022 |
C-reactive protein levels and prevalence of leukopenia in patients with inflammatory bowel disease treated with azathioprine and/or mesalazine: a real-life study.
Topics: Adult; Azathioprine; C-Reactive Protein; Humans; Inflammatory Bowel Diseases; Leukopenia; Mesalamine; Prevalence | 2022 |
Ulcerative colitis-associated bronchiectasis: A rare extraintestinal manifestation of inflammatory bowel disease: A case report.
Topics: Adult; Azathioprine; Bronchiectasis; Chronic Disease; Colitis, Ulcerative; Cough; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Young Adult | 2022 |
Epidemiological Trends of Pediatric Inflammatory Bowel Disease in Korea: A Multicenter Study of the Last 3 Years Including the COVID-19 Era.
Topics: Azathioprine; Colitis, Ulcerative; COVID-19; Crohn Disease; Humans; Inflammatory Bowel Diseases; Infliximab; Leukocyte L1 Antigen Complex; Mesalamine; Pandemics; Republic of Korea; Retrospective Studies | 2022 |
Efficacy and Safety of Sulfasalazine Suspension in Children With Ulcerative Colitis.
Topics: Adolescent; Azathioprine; Child; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Retrospective Studies; Sulfasalazine; Treatment Outcome | 2023 |
Use of Novel Biological Agent in Severe Ulcerative Colitis with Poor Response to Initial Therapy: A Case Report.
Topics: Adalimumab; Azathioprine; Biological Factors; Colitis, Ulcerative; Humans; Inflammation; Mesalamine | 2022 |